Closed · CDC-RFA-DD15-1506 · CFDA 93.073 · Discretionary

Surveillance of Congenital Heart Defects Across the Lifespan

Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.

$250K-$500K
Award range
Closed
Status
June 1, 2015
Close date
6
Expected awards

The verdict

Surveillance of Congenital Heart Defects Across the Lifespan is a closed discretionary listing from Centers for Disease Control and Prevention that offered $250,000 -- $500,000 across 6 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.

$250K-$500K
award range
Closed
application status
6
expected awards
93.073
CFDA program

Archived opportunity record

Surveillance of Congenital Heart Defects Acro… is closed (last close June 1, 2015). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 1, 2015

Posted Mar 24 Closes Jun 1

Est. Total Funding

$9,600,000

Expected Awards

6

Instrument

Cooperative Agreement

Description

This new, competitive FOA will expand the National Center on Birth Defects and Developmental Disabilities’ programs conducting birth defects surveillance with a focus on congenital heart defects (CHDs) among individuals of all ages. The National Center on Birth Defects and Developmental Disabilities (NCBDDD), Division of Birth Defects and Developmental Disabilities (DBDDD) seeks to fund collaborative projects to: 1) Category A: Build on existing infrastructure for population-based CHDs surveillance to (i) conduct longitudinal follow up of both adolescents and adults identified having a CHD, (ii) identify factors associated with optimal healthcare and improved outcomes, (iii) evaluate factors that impede appropriate transition from pediatric to adult care, (iv) expand surveillance activities to include the lifespan, if possible, and (v) develop pilot projects to translate public health best practices into action; and 2) Category B: Develop and implement innovative approaches for conducting population-based surveillance of CHDs in adolescents and adults, and if possible, across the lifespan, by linking existing data sources. Surveillance data will be used for descriptive epidemiology, to identify comorbidities, and examine healthcare utilization and referral to timely and appropriate services. CHDs are one of the most prevalent birth defects in the United States affecting about one percent of all births and are a leading cause of birth defect-associated infant mortality, morbidity, and healthcare costs. However, most current efforts to conduct population-based surveillance of CHDs have focused on monitoring newborns, and little data exist on the prevalence and descriptive epidemiology of CHDs beyond early childhood in the United States. Improvements in treatment of CHDs and consequently in survival have resulted in many individuals, even those affected by a very severe CHD, living into adolescence and adulthood. Current estimates suggest there are over 2 million people living with a CHD in the United States, including over one million adults; about 12% of these affected adults have a severe CHD. Despite the public health burden, the lack of population-based surveillance for CHDs among individuals of all ages in the United States precludes reliable data on the actual prevalence, and the type and number of health services required to address the health needs of these individuals, costs of such health services, and longer term outcomes including comorbidities and survival of individuals living with CHDs. Given that many individuals with CHD are living into adolescence and adulthood, they will need to transition their care from pediatric to adult-centered care. In the absence of structured programs to guide this transition, there can be delayed or inappropriate care, improper timing of the transfer of care, and undue emotional and financial stress on the patients, their families, and the healthcare system. Without appropriate transition, patients may not stay in care and be lost to follow-up. There is a need for furthered understanding of transition of care issues and perceptions of need for specialty care. The federal Patient Protection and Affordable Care Act (PL 111-148, Section 10411) authorized CDC to “enhance and expand infrastructure to track the epidemiology of congenital heart disease and to organize such information into a nationally-representative, population-based surveillance system” for the purpose of facilitating “further research into the types of health services patients use and to identify possible areas for educational outreach and prevention.” The FY12 budget states: “Congenital Heart Disease.- The conferees are concerned that there is a lack of rigorous epidemiological and longitudinal data on individuals of all ages with congenital heart disease and has included funding to begin to compile this information. The conferees are particularly interested in information on prevalence, barriers to effective care, survival outcomes and neurocognitive outcomes.” The FY14 Omnibus budget held agreement for language in Senate Report 113-71 expanding CHD work at CDC and states: “Congenital Heart Defects [CHD].—CHD continue to be the most common birth defect and leading cause of infant mortality in the United States. Even those who receive successful intervention will need lifelong, costly, specialized cardiac care. Estimates suggest there are over 2 million people alive today with CHDs. The Committee commends CDC for its increasing efforts to address the lifelong needs of this growing population, particularly in collaboration with other Federal agencies and private organizations. However, the Committee is concerned that there continues to be a lack of rigorous epidemiological and longitudinal data on individuals of all ages with CHD and includes funding to continue initial efforts to compile this information.” The report language also provided guidance “to collect and analyze nationally representative, population-based epidemiological and longitudinal data on infants, children, and adults, with the goal of improving estimates of CHD incidence, prevalence, and disease burden, which can be used to better assess the public health impact of this condition.” In FY12, CDC funded 3 grantees under FOA #DD12-1207 to pilot innovative methods of conducting population-based surveillance of adolescents and adults with CHDs by linking available existing data sources. Products developed under FOA #DD12-1207 include a common case definition, core variable set, and an Access database for data transmission to CDC. These products will be the minimum surveillance requirements for both categories A and B applicants. Refer to the www.cdc.gov/ncbddd website to view these documents.

Wide-open applicant board · 16 Grants.gov doors

Surveillance of Congenital Heart Defects Acro… prints 16 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +12 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). Only 6 other Centers for Disease Control and Prevention listings share this exact eligibility-code string (0% of 1,728).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)
Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Bill Paradies wep2@cdc.gov

What to do next

Surveillance of Congenital Heart Defects Acro… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.073 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants